4-aminopyridine has been researched along with scopolamine hydrobromide in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Sapru, H; Sundaram, K | 1 |
| Xu, JH; Yang, BZ; Zhou, HJ | 1 |
| Beninger, RJ; Boegman, RJ; Jhamandas, K; Mallet, PE; Wirsching, BA | 1 |
| Li, BH; Xiong, YQ | 1 |
| Cao, H; Xu, JH; Zheng, JH | 1 |
| Barrett, JE; Rosenzweig-Lipson, S; Thomas, S | 1 |
| Poorheidari, G; Pratt, JA; Stanhope, KJ | 1 |
| Barrett, JE; Vanover, KE | 1 |
| Aksu, F; Baysal, F; Inan, SY | 1 |
| Barocelli, E; Bertoni, S; De Vita, D; Flammini, L; Musella, A; Scipione, L | 1 |
12 other study(ies) available for 4-aminopyridine and scopolamine hydrobromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Cholinergic nerve terminals in the ventrolateral medullary pressor area: pharmacological evidence.
Topics: 4-Aminopyridine; Acetylcholine; Amifampridine; Aminopyridines; Animals; Blood Pressure; Hemicholinium 3; Medulla Oblongata; Microinjections; Nerve Endings; Parasympathetic Nervous System; Pirenzepine; Receptors, Muscarinic; Scopolamine; Sympathetic Nervous System | 1988 |
[Antagonism of 4-aminopyridine on the central nervous system depressant effects of scopolamine in rabbits].
Topics: 4-Aminopyridine; Aminopyridines; Animals; Central Nervous System Depressants; Central Nervous System Stimulants; Electroencephalography; Female; Male; Physostigmine; Rabbits; Scopolamine | 1984 |
Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats.
Topics: 4-Aminopyridine; Amifampridine; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Physostigmine; Potassium Channels; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Scopolamine | 1995 |
[Inhibitory action of chlorpromazine on intestinal movement in mice and its antagonistic agents].
Topics: 4-Aminopyridine; Animals; Chlorpromazine; Cholinesterase Inhibitors; Defecation; Drug Synergism; Female; Gastrointestinal Motility; Guinea Pigs; In Vitro Techniques; Male; Mice; Parasympathomimetics; Scopolamine | 1994 |
[Intracerebral-ventricular injection of 4-aminopyridine induced convulsion in rabbits].
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Disease Models, Animal; Female; Haloperidol; Injections, Intraventricular; Male; Phentolamine; Rabbits; Scopolamine; Seizures | 1993 |
Attenuation of the locomotor activating effects of D-amphetamine, cocaine, and scopolamine by potassium channel modulators.
Topics: 4-Aminopyridine; Animals; Apamin; Central Nervous System Stimulants; Cocaine; Cromakalim; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Muscarinic Antagonists; Potassium Channels; Quinine; Scopolamine | 1997 |
Effects of the potassium channel blockers, apamin and 4-aminopyridine, on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitor E2020.
Topics: 4-Aminopyridine; Animals; Apamin; Choice Behavior; Cholinesterase Inhibitors; Conditioning, Operant; Donepezil; Indans; Male; Muscarinic Antagonists; Piperidines; Potassium Channel Blockers; Potassium Channels; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine | 1998 |
An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response.
Topics: 4-Aminopyridine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Indoles; Learning; Male; Memory; Mice; Models, Psychological; Muscarinic Antagonists; Pyridines; Scopolamine; Serotonin Receptor Agonists | 1998 |
The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice.
Topics: 4-Aminopyridine; Amifampridine; Amnesia; Animals; Apamin; Avoidance Learning; Electroshock; Male; Mice; Muscarinic Antagonists; Potassium Channel Blockers; Retention, Psychology; Scopolamine | 2000 |
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity.
Topics: 4-Aminopyridine; Amnesia; Animals; Avoidance Learning; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Kinetics; Rats; Scopolamine | 2008 |